Caruso G

ORCID: 0000-0001-5501-1936 · 10 papers in corpus
review 2026
Frontiers in bioscience (Landmark edition) ·doi:10.31083/FBL45414

Endometriosis is a chronic pathological condition characterized by the growth of endometrial-like tissue outside the uterine cavity and is frequently associated with severe pain, persistent inflammation, and fibrosis within the pelvic regio…

observational 2026
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2026.1869937

INTRODUCTION: Endometriosis is a common, chronic, estrogen-dependent gynecological disorder characterized by the growth of endometrial-like tissue outside the uterus and frequently associated with pelvic pain and infertility. Despite its hi…

review 2025
JAMA ·doi:10.1001/jama.2025.9495

IMPORTANCE: Ovarian cancer is the eighth most common cause of cancer and cancer death in women worldwide. In 2022, ovarian cancer was diagnosed in approximately 324 398 individuals, and 206 839 died of ovarian cancer worldwide. In 2025, it …

other 2025
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113945
observational 2024
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.11.015

OBJECTIVE: To compare the effects of five combined oral contraceptives (COCs) - ethinylestradiol (EE) 30 μg/dienogest (DNG) 2 mg, EE 20 μg/drospirenone (DRSP) 3 mg, 17β-estradiol (E2) 1.5 mg/nomegestrol acetate (NomAc) 2.5 mg,estetrol (E4) …

review 2022
Journal of clinical medicine ·doi:10.3390/jcm11030810

Among the components of a healthy life, sexuality is essential, contributing to both the psychophysical and social well-being of women and, consequently, to their quality of life. A poorly investigated standpoint is the acceptability of con…

rct 2022
BMC women's health ·doi:10.1186/s12905-022-01737-7

BACKGROUND: To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (C…

rct 2022
·doi:10.21203/rs.3.rs-1323526/v1

Abstract Background: To evaluate the effects of a combined oral contraceptive containing 1.5mg 17b-estradiol (E2) and 2.5mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic …

meta-analysis 2021
Journal of gynecologic oncology ·doi:10.3802/jgo.2021.32.e83

OBJECTIVE: To investigate current evidence on oncological, fertility and obstetric outcomes of patients with stage I cervical cancer of 4 cm or larger undergoing fertility-sparing surgery (FSS). METHODS: Systematic review of studies includ…

other 1989
Minerva ginecologica

Six cases of cervical endometriosis out of 420 colposcopies (1.42%) are described. The data suggest a correlation between electrocautery or other cervical trauma and cervical endometriosis. This study confirms that colposcopic examination i…